论文信息 - Abstract PD3-01: BluePrint performance in predicting pertuzumab benefit in genomically HER2-positive patients: A biomarker analysis of the APHINITY trial - 字舞流文

Abstract PD3-01: BluePrint performance in predicting pertuzumab benefit in genomically HER2-positive patients: A biomarker analysis of the APHINITY trial

R. Bernards | R. Gelber | S. Loi | M. Piccart | J. Paulson | C. Dreezen | S. Loibl | F. André | H. Bonnefoi | D. Fumagalli | L. Mittempergher | I. Krop | C. Caballero | L. Veer